Weishuai S. Liu
State Key Laboratory Of Draggability Evaluation And Systematic Translational Medicine, Tianjin Key Laboratory Of Digestive Cancer
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Syrosingopine enhances immune checkpoint blockade efficacy by inhibition of MCTs and metabolic reprogramming in triple-negative breast cancer.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 02, 2025
Research on precision treatment of pancreatic cancer targeted by antibody-drug conjugates.
Journal: Bioscience trends
Published: November 19, 2025
The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer.
Journal: Genomics
Published: March 25, 2025
Multi-functional electrochemiluminescence biosensor for efficient capture, elimination, and sensitive monitoring of Staphylococcus aureus.
Journal: Biosensors & bioelectronics
Published: October 11, 2024
Metabolic and Immunological Implications of MME+CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities.
Journal: Biological procedures online
Published: June 17, 2024
Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer.
Journal: Nature communications
Published: June 12, 2024
A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma.
Journal: American journal of cancer research
Published: September 21, 2023
Ultrasensitive electrochemiluminescence biosensor based on polymethylene blue nanoparticles and DNA network for Staphylococcus aureus detection.
Journal: Food chemistry
Published: September 12, 2023
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 17, 2023
Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: February 19, 2023
CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 30, 2022
Last Updated: 09/26/2026